20.08.2010 14:30:00
|
Angeion and Data Innovations Partner to Create New MedGraphics BreezeConnect™
Angeion Corporation (NASDAQ: ANGN) today announced that it has partnered with Data Innovations to create MedGraphics BreezeConnect, a software interface that provides interfacing options in one comprehensive solution. BreezeConnect is currently available in the United States and is expected to launch internationally in September.
BreezeConnect, part of Angeion’s MedGraphics product line, incorporates Data Innovations’ Instrument Manager™ (IM) to provide connectivity between MedGraphics cardiorespiratory diagnostic systems and a hospital’s electronic medical records. This IMpowered™ solution gives clinicians the ability to improve workflow, reduce department costs, increase productivity and meet "meaningful use” criteria that could qualify their facility for government grant money.
"MedGraphics is expanding its information management product offering both domestically and abroad,” said Rodney A. Young, President and Chief Executive Officer of Angeion. "While we have more than 10 years of interfacing experience, our partnership with Data Innovations gives us a next-generation global solution for our growing customer base. Our new BreezeConnect adds the functionality of computerized physician order entry that can help our customers reduce errors by minimizing the ambiguity of handwritten orders.”
"Data Innovations is proud to partner with MedGraphics and we are excited to expand into the cardiorespiratory diagnostics market,” said Lisa Bromley, Worldwide Director of Business Development for Data Innovations. "We look forward to bringing additional value and efficiencies to MedGraphics’ global customer base through the introduction of innovative connectivity and workflow solutions. Additionally, with such a strong emphasis placed on improving patient care through the use of electronic medical records, our companies worked closely together to create a solution to help physicians achieve meaningful use.”
BreezeConnect provides physicians with rapid and complete access to patient diagnostic records via a central shared database. This allows healthcare facilities to enhance the quality of patient care and improve system efficiencies. In addition, BreezeConnect is more user-friendly, featuring multilingual capabilities, international technical staff and call centers, and a comprehensive support system.
About Angeion Corporation
Founded in 1986, Angeion
Corporation acquired Medical Graphics Corporation in December 1999.
Medical Graphics develops, manufactures and markets non-invasive
cardiorespiratory diagnostic systems that are sold under the MedGraphics
(www.medgraphics.com)
and New Leaf (www.newleaffitness.com)
brand and trade names. These cardiorespiratory diagnostic systems have a
wide range of applications in healthcare as well as health and fitness.
The Company’s products are sold internationally through distributors and
in the United States through a direct sales force that targets heart and
lung specialists located in hospitals, university-based medical centers,
medical clinics and physicians’ offices, pharmaceutical companies,
medical device manufacturers, clinical research organizations, health
and fitness clubs, personal training studios, and other exercise
facilities. For more information about Angeion, visit www.angeion.com.
About Data Innovations
Founded in 1989, Data Innovations
(DI) has grown to more than 85 specialists and $21 million in annual
sales, becoming the world’s largest clinical and blood laboratory
middleware company. With a focus solely on laboratory data management
and offices in the United States, Belgium, Brazil, China, France, and
the United Kingdom, DI is the only middleware company with a true global
scope. Through more than 40 industry business partnerships and working
directly with laboratory end users, DI has installed more than 6,500
middleware systems in 65 countries. Instrument Manager (IM) and
Laboratory Production Manager (LPM) represent the most complete
offerings in the market for pre-analytical, analytical, and
post-analytical sample processing and non analytical tasks such as
equipment maintenance. Almost 1,000 different instruments, automation
systems, and information systems are supported. Equally important as
DI’s products are its services, which include comprehensive and
proactive support, a variety of training options, and on-site
consulting. Labs are continually challenged to decrease turnaround time
while handling higher volume and maintaining high data quality despite
labor shortages and tightening budgets. DI offerings help the laboratory
successfully meet these challenges and supports the company’s vision: To
positively impact patient care by applying the discipline of customer
intimacy in partnerships that increase efficiencies and improve workflow
through delivery of the world’s best total middleware solutions to the
clinical laboratory.
Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu MGC Diagnostics Corporationmehr Nachrichten
Keine Nachrichten verfügbar. |